NBIX

Neurocrine Biosciences, Inc. NBIX

$170.88 -0.67 (-0.39%)

Neutral · +0.16σ

+ Compare Open in Sniper

Mkt cap $17.3B

P/E 26.6

Day $169.26 – $172.57

52wk $122.14 – $181.18

Avg vol —

Beta —

Div yld —

Next earnings —

Quick read

Plain English

Neurocrine Biosciences, Inc. is a healthcare company listed in the US.

NBIX last traded at $170.88, down 0.4% on the day; that's in the upper part of its 52-week range ($122.14–$181.18). Right now it's trading close to its recent average, with no strong stretch in either direction.

Earnings reports are the biggest scheduled catalysts to keep an eye on, and day to day, watch whether it holds above or slips below its recent average.

A plain-English snapshot built from the data on this page — not investment advice. Always do your own research.

132-Day Trend Zones

Full chart →

21 EMA +1 ATR +2 ATR −2 ATR

—

O — H — L — C —

— —

Valuation & accounting

Valuation desk →

Our cash-flow model pegs fair value near $332.85 (fair range $85–$333); today's price leaves a +48% cushion below that estimate. The model's verdict is “Deep value” and accounting quality screens as Strong. Model estimates only — do your own due diligence.

Intrinsic (DCF)

$332.85

Fair-value range

$85.35 – $332.85

Margin of safety

+48%

Verdict

Deep value

Accounting quality Strong

✓ More cash than debt
✓ Quick ratio 2.69 (antifragile)
✓ Current ratio 3.39 (antifragile)
✓ Debt/equity 0.42 (antifragile)

⚠ Receivables growing faster than revenue

Price implies ~13% growth (vs trailing rev yoy). Model estimate — do your own due diligence.

Key statistics

All statistics →

NBIX is a $17.3 billion company, priced at 27× last year's earnings.

Mkt cap $17.3B

P/E ttm 26.6

Fwd P/E —

Beta —

Day range $169.26 – $172.57

52w range $122.14 – $181.18

Avg vol —

RSI(2) 4.2

ROE —

Net mgn —

FCF mgn 20.6%

Debt/Eq 0.14

Div yld —

Sector Healthcare

Industry Drug Manufacturers - Specialty & Generic

Next earn —

52-week range · today's price

$122.14$181.18